Molecular Cancer Therapeutics· @MCT_AACR · X·· 2026-04-21评分60
正文 · 机器翻译
现已上线！与一张 #AACR26 海报同步发布：#FirstDisclosure of ABL209 (NEOK002)，一款具有抗肿瘤活性且治疗窗更宽的 EGFRxMUC1 双特异性 TOP1i ADC
https://
aacrjournals.org/mct/article/doi/10.1158/1535-7163.MCT-26-0088
…
热度 0 · 0 赞 · 0 回复 · 0 转发
会议摘要
1726按 代号 NEOK002 对上
NEOK002 (ABL209): Redesigning an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic windowBora Lee, Hyeon Ji Park, Byeong Min Yoo, Hangil Kim, Junyoung Kim, Arim Seo, Youngeun Hong, Donghoon Yeom, Yong-Gyu Son, Jaehyun Eom, Byungje Sung, Jinhyung Ahn, Jinwon Jung, Weon-Kyoo You, Sang Hoon Lee
读摘要原文 →来源：Molecular Cancer Therapeutics · x.com